Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy
J. Clin. Invest. 119:7 doi:10.1172/JCI33816
[Go to this article.]

Problems with a PDF?

PDF - Download (2.74 MB)